This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-09-0577v1 69/18/7252    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Qu, P. Articles by Yan, C. PubMed PubMed Citation Articles by Qu, P. Articles by Yan, C.

Matrix Metalloproteinase 12 Overexpression in Lung Epithelial Cells Plays a Key Role in Emphysema to Lung Bronchioalveolar Adenocarcinoma Transition

¹ The Center for Immunobiology, Simon Cancer Center and ² Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana and ³ Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Requests for reprints: Cong Yan, The Center for Immunobiology and Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Walther Hall C418, 980 W. Walnut Street, Indianapolis, IN 46202-5188. Phone: 317-278-6005; Fax: 317-278-7030; E-mail: coyan{at}iupui.edu or Hong Du, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. Phone: 513-636-7136; E-mail: Hong.Du{at}cchmc.org.

Key Words: inflammation • lung cancer • MMP12

Chronic obstructive pulmonary disease (COPD) and lung cancer are two diseases that are related to smoking in humans. The molecular mechanism linking these two diseases is poorly understood. Matrix metalloproteinase 12 (MMP12) is a member of the MMP family, which can be induced by smoking. Because MMP12 overexpression in epithelial cells has been reported in inflammation-triggered lung remodeling, a murine CCSP-rtTA/(tetO)₇-MMP12 bitransgenic model was created. In this model, MMP12-Flag fusion protein overexpression and its increased enzymatic activity were observed in the lung in an inducible manner, which led to inflammatory cell infiltration and increased epithelial growth. In sequential events, spontaneous emphysema and bronchioalveolar adenocarcinoma were developed as a result of MMP12 overexpression. During this process, the concentration of interleukin-6 was steadily increased in bronchioalveolar lavage fluid, which activated the oncogenic signal transducer and activator of transcription 3 (Stat3) in alveolar type II epithelial cells. Expression of Stat3 downstream genes that are known to stimulate inflammation and tumor formation was significantly increased in the lung. When tested in humans, MMP12 up-regulation was highly associated with COPD and lung cancer in patients. Together, these studies support that MMP12 is a potent proinflammatory and oncogenic molecule. MMP12 up-regulation plays a critical role in emphysema to lung cancer transition that is facilitated by inflammation. [Cancer Res 2009;69(18):7252–61]